SCHEMBL2519749

SCHEMBL2519749

c1ccc(-c2cccc3cc4ccccc4c(-c4ccccc4)c23)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 1/20 0.59
NQO2 P16083 1/20 0.46
MEN1 O00255 5/20 0.46
KMT2A Q03164 5/20 0.46
KDM4E B2RXH2 3/20 0.46
HPGD P15428 3/20 0.46
ALDH1A1 P00352 2/20 0.46
MAPT P10636 1/20 0.46
MPI P34949 1/20 0.46
GPR84 Q9NQS5 3/20 0.45
ERBB2 P04626 1/20 0.44
CYP1A2 P05177 1/20 0.44
FYN P06241 1/20 0.44
MAOA P21397 1/20 0.44
ACHE P22303 1/20 0.44
AHR P35869 1/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
CASP1 P29466 1/20 0.44
HIF1A Q16665 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4845570 0.94 CES1 (0.61) CES1NQO2MEN1KMT2AKDM4E
SCHEMBL25125398 0.91 GPR84 (0.50) CES1NQO2MEN1KMT2AKDM4E
SCHEMBL25125399 0.91 GPR84 (0.50) CES1NQO2MEN1KMT2AKDM4E
SCHEMBL28560513 0.89 CES1 (0.56) CES1NQO2MEN1KMT2AKDM4E
SCHEMBL29220862 0.89 CES1 (0.56) CES1NQO2MEN1KMT2AKDM4E
SCHEMBL21358003 0.89 CES1 (0.56) CES1NQO2MEN1KMT2AKDM4E
SCHEMBL29034309 0.89 CES1 (0.51) CES1NQO2MEN1KMT2AKDM4E
SCHEMBL21838774 0.88 CES1 (0.54) CES1NQO2MEN1KMT2AKDM4E
SCHEMBL31240158 0.88 CES1 (0.54) CES1NQO2MEN1KMT2AKDM4E
SCHEMBL4895197 0.88 GPR84 (0.48) CES1NQO2MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10739334-B2 Capsule suitable for non-invasive simultaneous oxygen content and temperature sensing in a living object MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) 2020-08-11 US disclosed
EP-3274420-B1 CAPSULE SUITABLE FOR NON-INVASIVE SIMULTANEOUS OXYGEN CONTENT AND TEMPERATURE SENSING IN A LIVING OBJECT MAX PLANCK GESELLSCHAFT (DE) 2019-01-30 EP disclosed
US-20180106785-A1 CAPSULE SUITABLE FOR NON-INVASIVE SIMULTANEOUS OXYGEN CONTENT AND TEMPERATURE SENSING IN A LIVING OBJECT MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) 2018-04-19 US disclosed
EP-3274420-A1 CAPSULE SUITABLE FOR NON-INVASIVE SIMULTANEOUS OXYGEN CONTENT AND TEMPERATURE SENSING IN A LIVING OBJECT Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2018-01-31 EP disclosed
WO-2016150677-A1 CAPSULE SUITABLE FOR NON-INVASIVE SIMULTANEOUS OXYGEN CONTENT AND TEMPERATURE SENSING IN A LIVING OBJECT MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2016-09-29 WO disclosed
EP-3072942-A1 CAPSULE SUITABLE FOR NON-INVASIVE SIMULTANEOUS OXYGEN CONTENT AND TEMPERATURE SENSING IN A LIVING OBJECT Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2016-09-28 EP disclosed
US-8729220-B2 Annellated dithiophene copolymers BASF SE (DE) 2014-05-20 US disclosed
CN-103402981-A Compound having substituted triphenylene ring structure and organic electroluminescent device HODOGAYA CHEMICAL CO LTD 2013-11-20 CN disclosed
EP-2553743-A1 ANNEALED DITHIOPHENE COPOLYMERS BASF SE (DE) 2013-02-06 EP disclosed
CN-102834945-A Annealed dithiophene copolymers BASF SE 2012-12-19 CN disclosed
EP-1743011-A1 ELECTROLUMINESCENT DEVICE CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) 2007-01-17 EP disclosed
US-20060226766-A1 Electroluminescent device CIBA SPECIALTY CHEMICALS CORP. 2006-10-12 US disclosed
US-20060135766-A1 Electroluminescent device CIBA SPECIALTY CHEMICALS CORP. 2006-06-22 US disclosed
EP-1660609-A1 ELECTROLUMINESCENT DEVICE Ciba SC Holding AG (CH) 2006-05-31 EP disclosed
WO-2005105950-A1 ELECTROLUMINESCENT DEVICE CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2005-11-10 WO disclosed
WO-2005023960-A1 ELECTROLUMINESCENT DEVICE CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2005-03-17 WO disclosed
US-6821643-B1 SATISFACTORY EMISSION IN THE VISIBLE SPECTRUM FROM BLUE TO LONGER WAVELENGTH REGIONS XEROX CORPORATION 2004-11-23 US disclosed
US-6229012-B1 ORGANIC ELECTROLUMINESCENT DEVICES XEROX CORPORATION 2001-05-08 US disclosed
US-6225467-B1 UNIFORM LUMINESCENCE, ELECTROLUMINESCENT EFFICIENCY, DURABILITY, LOW DRIVING VOLTAGE; FOR USE IN FLAT-PANEL EMISSIVE DISPLAY TECHNOLOGIES, INCLUDING TELEVISION SCREENS, COMPUTER SCREENS XEROX CORPORATION 2001-05-01 US disclosed
US-6057048-A Electroluminescent (EL) devices XEROX CORPORATION (US) 2000-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135766-A1 Electroluminescent device TAAR5, TYR, TRPC5 CES1 4424/4885NQO2 2539/4885MEN1 1125/4885
US-20060226766-A1 Electroluminescent device PNPO, DDT, PPOX CES1 3762/4885NQO2 1282/4885MEN1 1115/4885
US-10739334-B2 Capsule suitable for non-invasive simultaneous oxygen content and temperature sensing in a living object SQOR, SIRT3, NQO1 CES1 4688/4885NQO2 236/4885MEN1 1126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.